Kenyou shares Millinon injection USP approved by U.S.
-
Last Update: 2020-05-30
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Milinon is a phosphatedase inhibitor class strong heart medicine, has the effect of dilating the blood vessel smooth muscle, can reduce the heart load, but also excellently improve the kidney and muscle blood supply, mainly used for the treatment of artichokes, diuretics, vasodils treatment is ineffective or ineffective causes caused by acute, chronic stubborn congestive heart failureSeptember 7, 2018, Kenyou shares on the Millinon injection USP for the first time to the United States FDA registration application and acceptance, on March 24, 2020 received notice from the U.SFDA, Kenyou shares in the drug in the above three specifications of the ANDA application approvedSo far, Jianyou shares in the Milinon injection USP research and development project has invested research and development costs of about 13.3325 million yuan.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
